Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Josh Byrd Uses Songwriting Experience to Tell the Patient Story

Like most marketers, Josh Byrd, VP of Marketing at Relatient, has many passions. Outside of his marketing work with Relatient, Byrd is a professional country music songwriter. And it’s this ability to tell a story in song that strengthens Byrd’s abilities as a marketer. Byrd joined David Kemp on the Highway to Health to talk…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Like most marketers, Josh Byrd, VP of Marketing at Relatient, has many passions. Outside of his marketing work with Relatient, Byrd is a professional country music songwriter. And it’s this ability to tell a story in song that strengthens Byrd’s abilities as a marketer. Byrd joined David Kemp on the Highway to Health to talk about his love for marketing and how merging passions is a recipe for success.

“Good marketing is about connection,” Byrd said. “Whether you’re writing a song or a blog, or a podcast, or a white paper, or anything, you’re really searching for that emotional connection.”

Byrd began his journey by mixing his dream of country music fame with some paying marketing gigs. And never one to pass down an opportunity when it came his way, Bryd soon found marketing an offer he couldn’t refuse. New passions emerged, and he discovered working for startups was an exciting area to practice his marketing abilities. Articulating a startup’s story happened to be up Byrd’s ally. “It wasn’t all too different from a music journey, right? It’s helping somebody tell their story.”

Eventually, Byrd worked for a healthcare startup, helping patients understand the payment process better. And now, working at Relatient, Byrd gets to focus on patient engagement at an even deeper level. “We’re working on the scheduling and messaging side of things to make sure that patients are involved in their care from the get-go.”

There is no end to challenges in healthcare, but success is always a corner away with the right tools and guidance. Patient engagement is an area ripe for improvement, and it’s a rewarding challenge that Byrd said brings purpose and meaning to his work. “Last year, Relatient engaged with we 50 million patients. That’s 50 million opportunities to make someone’s life better.”

More Like This Story:

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Educating Customers Will Be Key to Balancing Customers Expectations With Healthcare Plans

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512